Açıklama
Compilation of preclinical and clinical outcomes for substances targeting mitochondrial oxidative stress in neurodegenerative disorders, summarizing the evidence for neuroprotective efficacy across multiple intervention strategies.
Figure 5
Source Paper
Mitochondria- and Oxidative Stress-Targeting Substances in Cognitive Decline-Related Disorders: From Molecular Mechanisms to Clinical Evidence.Cite This Figure
![Figure 5: Compilation of preclinical and clinical outcomes for substances targeting mitochondrial oxidative stress in neurodegenerative disorders, summarizing the evidence for neuroprotective efficacy across multiple intervention strategies.]() > Source: Imane Lejri et al. "Mitochondria- and Oxidative Stress-Targeting Substances in Cognitive Decline-Rel." *Oxidative medicine and cellular longevity*, 2019. PMID: [31214285](https://pubmed.ncbi.nlm.nih.gov/31214285/)
<figure> <img src="" alt="Compilation of preclinical and clinical outcomes for substances targeting mitochondrial oxidative stress in neurodegenerative disorders, summarizing the evidence for neuroprotective efficacy across multiple intervention strategies." /> <figcaption>Figure 5. Compilation of preclinical and clinical outcomes for substances targeting mitochondrial oxidative stress in neurodegenerative disorders, summarizing the evidence for neuroprotective efficacy across multiple intervention strategies.<br> Source: Imane Lejri et al. "Mitochondria- and Oxidative Stress-Targeting Substances in Cognitive Decline-Rel." <em>Oxidative medicine and cellular longevity</em>, 2019. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/31214285/">31214285</a></figcaption> </figure>